Zusammenfassung
Junge Patientinnen wünschen sich oft noch Kinder. Andererseits ist ihre Prognose per se schlechter als die älterer Patientinnen. Eine Therapie mit GnRH-Analoga gilt heute als sicher, um die Ovarialfunktion trotz Chemotherapie zu erhalten. Eine Fertilisierung von Mammakarzinompatientinnen ist innerhalb von wenigen Wochen möglich.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Bundred N, Kenemans P, Beckmann M, Foidart J, Kubista et al (2009) Effect of tibolone on breast cancer recurrence: liberate trial bone sub-study. Cancer Res 69(Suppl):79s
Holmberg L, Anderson H (2004) HABITS (hormonal replacement therapy after breast cancer – is it safe?), a randomised comparison: trial stopped. Lancet 363:453–455
Holmberg L, Iversen O, Rudenstam C et al (2008) Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Inst 100:475–482
Kendall A, Dowsett M, Folkerd E, Smith I (2006) Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 17:584–587
Kenemans P, Bundred N, Foidart JM, Kubista E et al (2009) Safety and efficacy of tibolone in breast cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 10(2):135–146
Lambertini M, Kroman N, Ameye L, Cordoba O, Pinto A, Benedetti G et al (2017a) Safety of pregnancy in patients with history of estrogen receptor positive breast cancer: long-term follow-up analysis. San Antonio Breast Cancer symposium, Abstract GS4-01 from a multicenter study. J Clin Oncol 345(15 Suppl):LBA 10066
Lambertini M, Moore H, Leonard R, Loibl S, Munster P, Bruzzone M et al (2017b) Pooled analysis of five randomized trials investigating temporary ovarian suppression with gonadotropin-releasing hormone analogs during chemotherapy as a strategy to preserve ovarian function and fertility in premenopausal early breast cancer patients. San Antonio Breast Cancer symposium, Abstract GS4-01
Lee S, Schover L, Partridge A et al (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:1–11
Loren A, Mangu P, Beck L, Brennan L, Magdalinski A, Partridge A et al (2013) Fertility preservation for patients with cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol 31:2500–2510
Morch L, Skovlund C, Hannaford P, Iversen L, Fielding S, Lidegaard O (2017) Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med 377:2228–2239
Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z (2005) Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23:4347–4353
Petru E, Wildt L, Stummvoll W, Singer C, Speiser P, Fischerlehner Reitsamer R et al (2009) Konsensus der österreichischen Gesellschaft für Gynäkologie und Geburtshilfe/Arbeitsgemeinschaft für Gynäkologische Onkologie: Fertilität, Kontrazeption und Hormonersatz bei onkologischen Patientinnen unter besonderer Berücksichtigung des Mammakarzinoms. Geburtsh Frauenheilk 69:1071–1077
Poorvu D (2017) Pregnancy after breast cancer: Results from a prospective cohort study. J Clin Oncol 35(15 Suppl):LBA 10065
Trinh XB, Tjalma W, Makar A, Buytaert G, Weyler J, Van Dam P (2008) Use of levonorgestrel-releasing intrauterine system in breast cancer patients. Fertil Steril 91:17–22
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Petru, E. (2019). Maligne Tumoren der Mamma: Fertilität, Kontrazeption und Hormonersatz. In: Petru, E., Fink, D., Köchli, O., Loibl, S. (eds) Praxisbuch Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57430-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-662-57430-0_2
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-57429-4
Online ISBN: 978-3-662-57430-0
eBook Packages: Medicine (German Language)